HCPCS Level II
›
Q codes
Q5129
Inj, vegzelma, 10 mg
Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 230 units per day (practitioner), rationale: CMS Policy